Innate Pharma announces its turnover for the first quarter of 2010 and updates on its cash situation

Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces a turnover of 0.1 million euros (105 thousand euros) for the first quarter of 2010, compared with 2.5 million euros (2,488 thousand euros) for the same period in 2009.